Given their involvement in a range of fusion events in blood cancers, we also included the T-cell receptor (TCRA/D, TCRB and TCRG) and immunoglobulin (IGH, IGL and IGK) loci on the blood panel (Supplementary Fig. 1a, b). The gene discussed is TRGC1; the disease is hematopoietic and lymphoid system neoplasm.